Emflaza

Product manufactured by Ptc Therapeutics, Inc.

Application Nr Approved Date Route Status External Links
NDA208684 None Oral None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Emflaza Is Indicated For The Treatment Of Duchenne Muscular Dystrophy (Dmd) In Patients 2 Years Of Age And Older. Emflaza Is A Corticosteroid Indicated For The Treatment Of Duchenne Muscular Dystrophy (Dmd) In Patients 2 Years Of Age And Older ( 1 )

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Deflazacort DEFLAZACORT ZINC4212809

Comments